Mitsubishi Gas Chemical Co Inc (4182):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mitsubishi Gas Chemical Co Inc (4182) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12371
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mitsubishi Gas Chemical Co Inc (MGC) is a chemicals company. It provides various products in a wide range of fields from basic chemicals to fine chemicals and functional materials. The company produces and sells xylene isomers, xylene derivatives and foaming plastics; inorganic chemicals and engineering plastics; methanol, amines, polyols, ammonia, methacrylates, enzymes, and crude oil; and printed circuit boards (PCB), PCB materials, and oxygen absorber. MGC serves automobiles, environment, electronics, life sciences, and energy sectors in Asia, North America, and other regions. It has manufacturing plants in Japan and R&D centers in Tokyo, Niigata, and Hiratsuka. MGC is headquartered in Tokyo, Japan.

Mitsubishi Gas Chemical Co Inc (4182) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Taiwan Sugar Enters into Partnership with Mitsubishi Gas Chemical and Cultivecs 10
Mitsubishi Gas Chemical and Nippon Kayaku Form Joint Venture 11
GlycoNex Enters Into Agreement With Mitsubishi Gas Chemical For Cancer Antibody 12
Mitsubishi Gas Chemical Co Inc – Key Competitors 13
Mitsubishi Gas Chemical Co Inc – Key Employees 14
Mitsubishi Gas Chemical Co Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitsubishi Gas Chemical Co Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Taiwan Sugar Enters into Partnership with Mitsubishi Gas Chemical and Cultivecs 10
Mitsubishi Gas Chemical and Nippon Kayaku Form Joint Venture 11
GlycoNex Enters Into Agreement With Mitsubishi Gas Chemical For Cancer Antibody 12
Mitsubishi Gas Chemical Co Inc, Key Competitors 13
Mitsubishi Gas Chemical Co Inc, Key Employees 14
Mitsubishi Gas Chemical Co Inc, Other Locations 15
Mitsubishi Gas Chemical Co Inc, Subsidiaries 16
Mitsubishi Gas Chemical Co Inc, Joint Venture 18

List of Figures
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mitsubishi Gas Chemical Co Inc (4182):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CIRCOR International, Inc. (CIR):石油・ガス:M&Aディール及び事業提携情報
    Summary CIRCOR International Inc (CIRCOR) is an industrial equipment company that designs, manufactures, and markets flow control solutions and engineered products and sub-systems. Its product offerings include integrated flow control solutions, high pressure pneumatic systems, valves, actuation, sw …
  • Gene Techno Science Co Ltd (4584)-製薬・医療分野:企業M&A・提携分析
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for cancer, intractable diseases and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-001 for immunological disease and oncology; GND-004, f …
  • Formosa Petrochemical Corp (6505):石油・ガス:M&Aディール及び事業提携情報
    Summary Formosa Petrochemical Corp (FPCC) refines crude oil and sells refined petroleum products and olefins. The company operates refinery and integrated petrochemical complexes. It imports, exports, markets, stores, and transports crude oil, gasoline, naphtha, propane and other feed stocks. The co …
  • Staples, Inc.:企業の戦略・SWOT・財務情報
    Staples, Inc. - Strategy, SWOT and Corporate Finance Report Summary Staples, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hexza Corp Bhd (HEXZA):企業の財務・戦略的SWOT分析
    Hexza Corp Bhd (HEXZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Powerflute Oy:企業の戦略的SWOT分析
    Powerflute Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Broadridge Financial Solutions, Inc. (BR):企業の財務・戦略的SWOT分析
    Broadridge Financial Solutions, Inc. (BR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Mercer International Inc (MERC):企業の財務・戦略的SWOT分析
    Mercer International Inc (MERC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • SunOpta Inc.:企業の戦略・SWOT・財務情報
    SunOpta Inc. - Strategy, SWOT and Corporate Finance Report Summary SunOpta Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • EMART Inc.:企業の戦略・SWOT・財務分析
    EMART Inc. - Strategy, SWOT and Corporate Finance Report Summary EMART Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CytoDel Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CytoDel Inc (CytoDel) is a biopharmaceutical company that utilizes molecular biology tools to produce recombinant derivatives of botulinum neurotoxin (BoNT). The company provides product portfolio such as Ctyo-111, an antidote to botulism; and Cyto-012 a recombinant BoNT derivative, among ot …
  • Venture Life Group Plc (VLG):製薬・医療:M&Aディール及び事業提携情報
    Summary Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The groups product and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, medical devices for improving minor aches and pains, dry eyes and itchy …
  • Texwinca Holdings Limited:企業の戦略・SWOT・財務情報
    Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Haisco Pharmaceutical Group Co Ltd (002653):製薬・医療:M&Aディール及び事業提携情報
    Summary Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations. The company offers parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive sy …
  • Grifols SA (GRF):製薬・医療:M&Aディール及び事業提携情報
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Young Innovations Inc:企業の戦略的SWOT分析
    Young Innovations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Petrofac Ltd (PFC)-石油・ガス分野:企業M&A・提携分析
    Summary Petrofac Limited (Petrofac) is an oilfield services company that provides integrated services to production and processing industries. It designs and builds oil and gas facilities; operates, maintains and manages facilities on behalf of its customers and trains personnel. It also develops an …
  • Mammoth Energy Services Inc (TUSK):石油・ガス:M&Aディール及び事業提携情報
    Summary Mammoth Energy Services Inc (Mammoth) is a provider of an integrated oilfield services. Its suite of services include pressure pumping, infrastructure services, natural sand proppant, contract land and directional drilling, and remote accommodation. Mammoth serves companies involved in the e …
  • Rio Tinto:企業の戦略・SWOT・財務情報
    Rio Tinto - Strategy, SWOT and Corporate Finance Report Summary Rio Tinto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Evofem Inc-製薬・医療分野:企業M&A・提携分析
    Summary Evofem Inc (Evofem) is a healthcare solution provider that discovers, develops and commercializes prescription and consumer products. The company’s product pipeline includes amphora and nestorone. Evofem improves reproductive health and wellness options for women. It develops products for co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆